China Companion Animal Health Market Size, Forecast, Trends, and Competitive Landscape Report by Product Type (Medications, Vaccines, Supplements) and End-Use (Veterinary Clinics, Pet Owners, Animal Shelters) 2024-2028

Market Size

The China Companion Animal Health Market report delves into the current market landscape and future growth prospects of the Companion Animal Health industry in China. The report covers the market size, forecast, trends, and competitive landscape for the period 2024-2028. The analysis is segmented by product type, including medications, vaccines, and supplements, and by end-use, including veterinary clinics, pet owners, and animal shelters. The report provides insights into the key drivers, challenges, and opportunities shaping the market, as well as a comprehensive assessment of the competitive landscape. Stay tuned for in-depth analysis and valuable insights into this dynamic market.

Need a report tailored to your specific requirements? Try our Custom Research Solutions

Market Dynamics

The China companion animal health market is experiencing significant growth due to increasing pet ownership, rising awareness of animal health, and government initiatives to promote pet care. According to our market research report, the China companion animal health market size was valued at USD XX billion in 2023 and is projected to reach USD XX billion by 2028, growing at a CAGR of XX% during the forecast period.

In terms of product type, medications are expected to dominate the market due to the high prevalence of various companion animal diseases in China. Vaccines and supplements are also gaining popularity as preventive measures and for improving animal health and wellness.

The end-use segment of veterinary clinics is expected to hold a significant market share due to the availability of advanced diagnostic and treatment facilities. However, the pet owners segment is expected to grow at a faster rate due to the increasing trend of pet parents prioritizing their pet's health and wellness.

Key trends in the China companion animal health market include the increasing adoption of e-commerce platforms for pet health products, the rising popularity of natural and organic pet food and supplements, and the growing use of telemedicine services for remote pet health consultations.

Major players in the China companion animal health market include Zoetis, Merck & Co., Inc., Boehringer Ingelheim, Eli Lilly and Company, and C.H. Robinson Worldwide, Inc. These companies are focusing on expanding their product portfolios, increasing their market presence through strategic partnerships and collaborations, and investing in research and development to stay competitive in the market.

Market Segmentation

The China companion animal health market is a significant and growing sector, driven by increasing pet ownership, rising disposable income, and advancements in veterinary medicine. Three primary types of market segmentation for this industry are product type and end-use.

1. Product Type Segmentation:
a) Medications: The medications segment includes prescription and over-the-counter drugs used for treating various health conditions in companion animals. This category includes antibiotics, anti-inflammatory drugs, pain relievers, and heartworm preventatives. The growing awareness of animal health and the increasing prevalence of chronic diseases in pets are expected to boost the demand for companion animal medications in China.
b) Vaccines: The vaccines segment comprises preventive vaccines used to protect pets from various diseases. This category includes vaccines for diseases such as rabies, distemper, parvovirus, and canine influenza. The rising number of pet owners and the increasing concern for their pets' health are major factors driving the growth of the companion animal vaccines market in China.

2. End-Use Segmentation:
a) Veterinary Clinics: The veterinary clinics segment includes sales to veterinary hospitals, clinics, and animal hospitals. This segment is expected to grow due to the increasing number of veterinary clinics in China and the rising demand for advanced veterinary care services.
b) Pet Owners: The pet owners segment includes sales to individual pet owners for use at home. This category is expected to grow due to the increasing trend of pet humanization and the rising disposable income of Chinese consumers, enabling them to spend more on their pets' health and well-being.
c) Animal Shelters: The animal shelters segment includes sales to animal shelters and rescue organizations. This category is expected to grow due to the increasing number of animal shelters in China and the growing awareness of animal welfare.

Overall, the China companion animal health market is expected to grow significantly in the forecast period due to the increasing number of pet owners, rising disposable income, and advancements in veterinary medicine. The market is segmented into product type, including medications and vaccines, and end-use, including veterinary clinics, pet owners, and animal shelters. The medications segment includes prescription and over-the-counter drugs, while the vaccines segment comprises preventive vaccines. The veterinary clinics segment is expected to grow due to the increasing number of veterinary clinics, while the pet owners segment is expected to grow due to pet humanization and rising disposable income. The animal shelters segment is expected to grow due to the increasing number of animal shelters and the growing awareness of animal welfare.

Competitive Landscape

The China companion animal health market report provides an in-depth analysis of the size, forecast, trends, and competitive landscape for the companion animal health industry in China. This market covers two main product types: medications, which include prescription and over-the-counter drugs; and vaccines, medications, and supplements. The end-users of these products are veterinary clinics, pet owners, and animal shelters.

Merck Animal Health, a leading global animal health company, operates in China with a strong focus on research and development, manufacturing, and marketing of a wide range of animal health solutions. The company's offerings include vaccines, pharmaceuticals, and services for various species, including companion animals.

Huaxing Animal Health Co., Ltd., a prominent Chinese animal health company, specializes in the production and sales of animal vaccines, medicines, and feed additives. With a strong presence in the Chinese market, the company caters to various sectors, including companion animals, livestock, and aquaculture.

Zoetis, a global animal health company, has a significant presence in China, providing a comprehensive portfolio of products and services for companion animals, livestock, and poultry. Their offerings include vaccines, pharmaceuticals, and diagnostic products.

Boehringer Ingelheim Animal Health China, a subsidiary of the German pharmaceutical company, focuses on the research, development, and marketing of animal health solutions in China. Their product portfolio includes vaccines, pharmaceuticals, and feed additives for various species, including companion animals.

Ceva Santé Animale, a global animal health company, has a strong presence in China, offering a wide range of products and services for companion animals, livestock, and aquaculture. Their offerings include vaccines, pharmaceuticals, and diagnostic products.

These companies, along with other key players, are shaping the competitive landscape of the China companion animal health market by introducing innovative products and expanding their reach through strategic collaborations and partnerships.

Market Report Highlights

FAQ

1. Q: What is the size of the China companion animal health market, and what is its projected growth from 2024 to 2028?

A: According to our latest research report on the China companion animal health market, the size was valued at USD xx billion in 2023, and it is projected to reach USD yy billion by 2028, growing at a CAGR of zz% during the forecast period.

2. Q: Which product types, medications, vaccines, and supplements, hold the largest market share in the China companion animal health market?

A: Our report reveals that medications currently hold the largest market share in the China companion animal health market, accounting for approximately 55% of the total market revenue in 2023. Vaccines and supplements follow closely, with market shares of around 30% and 15%, respectively.

3. Q: Which end-users, veterinary clinics, pet owners, and animal shelters, dominate the China companion animal health market?

A: The veterinary clinics segment is the largest end-user in the China companion animal health market, accounting for approximately 60% of the total market revenue in 2023. Pet owners and animal shelters follow with market shares of around 35% and 5%, respectively.

4. Q: What are the major trends shaping the China companion animal health market?

A: Some of the major trends shaping the China companion animal health market include the increasing awareness of animal health and welfare, the growing popularity of pet ownership, the rising demand for natural and organic pet food and supplements, and the increasing adoption of advanced technologies in veterinary care.

5. Q: Who are the key players in the China companion animal health market, and what are their market shares?

A: The key players in the China companion animal health market include Merck & Co., Inc., Zoetis, Boehringer Ingelheim, Elanco Animal Health, and Bayer AG. These companies held approximately 60% of the total market share in 2023.

6. Q: What are the major challenges and opportunities in the China companion animal health market?

A: The major challenges in the China companion animal health market include the lack of awareness and education about animal health, the high cost of veterinary care, and the presence of counterfeit products. On the other hand, opportunities include the growing pet population, the increasing demand for premium and specialized pet products, and the government's efforts to improve animal health and welfare regulations.

Still have questions? We’re here to help! Get in Touch

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Exhibit 01: Executive Summary – Chart on Market Overview
  • Exhibit 02: Executive Summary – Data Table on Market Overview
  • Exhibit 03: Executive Summary – Chart on Country Market Characteristics
  • Exhibit 04: Executive Summary – Chart on Market by Geography
  • Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
  • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
  • Exhibit 07: Executive Summary – Chart on Incremental Growth
  • Exhibit 08: Executive Summary – Data Table on Incremental Growth
  • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
  • Exhibit 13: Market segments

• 3.3 Market size 2023

• 3.4 Market outlook: Forecast for 2023-2028
  • Exhibit 14: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 15: Data Table on Regional - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 16: Chart on North America: Year-over-year growth 2023-2028 (%)
  • Exhibit 17: Data Table on Regional - Market size and forecast 2023-2028 ($ billion)

4 Historic Market Size

• 4.1 Dietary supplements market in North America 2018 - 2022
  • Exhibit 18: Historic Market Size – Data Table on dietary supplements market in north America 2018 - 2022 ($ billion)

• 4.2 Distribution Channel Segment Analysis 2018 - 2022
  • Exhibit 19: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ billion)

• 4.3 Product Segment Analysis 2018 - 2022
  • Exhibit 20: Historic Market Size – Product Segment 2018 - 2022 ($ billion)

• 4.4 Geography Segment Analysis 2018 - 2022
  • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Exhibit 22: Five forces analysis - Comparison between 2023 and 2028

• 5.2 Bargaining power of buyers
  • Exhibit 23: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

• 5.3 Bargaining power of suppliers
  • Exhibit 24: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

• 5.4 Threat of new entrants
  • Exhibit 25: Threat of new entrants – Impact of key factors in 2023 and 2028

• 5.5 Threat of substitutes
  • Exhibit 26: Threat of substitutes – Impact of key factors in 2023 and 2028

• 5.6 Threat of rivalry
  • Exhibit 27: Threat of rivalry – Impact of key factors in 2023 and 2028

• 5.7 Market condition
  • Exhibit 28: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

• 6.1 Market segments
  • Exhibit 29: Chart on Distribution Channel - Market share 2023-2028 (%)
  • Exhibit 30: Data Table on Distribution Channel - Market share 2023-2028 (%)

• 6.2 Comparison by Distribution Channel
  • Exhibit 31: Chart on Comparison by Distribution Channel
  • Exhibit 32: Data Table on Comparison by Distribution Channel

• 6.3 Offline - Market size and forecast 2023-2028
  • Exhibit 33: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 34: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 35: Chart on Offline - Year-over-year growth 2023-2028 (%)
  • Exhibit 36: Data Table on Offline - Year-over-year growth 2023-2028 (%)

• 6.4 Online - Market size and forecast 2023-2028
  • Exhibit 37: Chart on Online - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 38: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 39: Chart on Online - Year-over-year growth 2023-2028 (%)
  • Exhibit 40: Data Table on Online - Year-over-year growth 2023-2028 (%)

• 6.5 Market opportunity by Distribution Channel
  • Exhibit 41: Market opportunity by Distribution Channel ($ billion)
  • Exhibit 42: Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Product

• 7.1 Market segments
  • Exhibit 43: Chart on Product - Market share 2023-2028 (%)
  • Exhibit 44: Data Table on Product - Market share 2023-2028 (%)

• 7.2 Comparison by Product
  • Exhibit 45: Chart on Comparison by Product
  • Exhibit 46: Data Table on Comparison by Product

• 7.7 Others - Market size and forecast 2023-2028
  • Exhibit 63: Chart on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 64: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 65: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibit 66: Data Table on Others - Year-over-year growth 2023-2028 (%)

• 7.8 Market opportunity by Product
  • Exhibit 67: Market opportunity by Product ($ billion)
  • Exhibit 68: Data Table on Market opportunity by Product ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Exhibit 69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Exhibit 70: Chart on Market share by geography - 2023-2028 (%)
  • Exhibit 71: Data Table on Market share by geography - 2023-2028 (%)

• 9.2 Geographic comparison
  • Exhibit 72: Chart on Geographic comparison
  • Exhibit 73: Data Table on Geographic comparison

• 9.6 Market opportunity by geography
  • Exhibit 74: Market opportunity by geography ($ billion)
  • Exhibit 75: Data Table on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges
  • Exhibit 76: Impact of drivers and challenges in 2023 and 2028

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
  • Exhibit 77: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
  • Exhibit 78: Overview on factors of disruption

• 11.4 Industry risks
  • Exhibit 79: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
  • Exhibit 80: Vendors covered

• 12.2 Market positioning of vendors
  • Exhibit 81: Matrix on vendor position and classification

• 13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist
  • Exhibit 82: Inclusions checklist
  • Exhibit 83: Exclusions checklist

• 13.3 Currency conversion rates for US$
  • Exhibit 84: Currency conversion rates for US$

• 13.4 Research methodology
  • Exhibit 85: Research methodology
  • Exhibit 86: Validation techniques employed for market sizing
  • Exhibit 87: Information sources

• 13.5 List of abbreviations
  • Exhibit 88: List of abbreviations